In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CooperVision and Ocular Sciences: Stronger as One

Executive Summary

Economies of scale and product breadth were behind the $1.2 billion merger of contact lens companies the Cooper Companies and Ocular Sciences. The combined company will be better positioned to benefit from the three drivers in the rapidly growing $6 billion worldwide contact lens market: the bulge in the youth population known as Echo Boomers; an increasing mix of advanced, premium priced products, and the worldwide increase of myopia.

You may also be interested in...



Deal Statistics Quarterly, Q3 2004

In this issue, we present another installment of our quarterly review of dealmaking-for July-September 2004. Our data comes from Windhover's Strategic Transactions Database, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.

UK’s CMA Issues Fines Over Fludrocortisone

The UK’s Competition and Markets Authority has issued fines of nearly £2.3m after formally concluding that three firms participated in illegal arrangements over fludrocortisone that violated competition law.

Topics

Related Deals

UsernamePublicRestriction

Register

ID1125347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel